Oliver Hampton

Chief Data Officer

Southwest Research Institute

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Oliver Hampton is the Chief Data Officer at Southern Research Institute in the United States. His research areas focus on multiple myeloma, with significant contributions in genomic classification, mitochondrial metabolism, and patient outcomes, as reflected in his recent articles. Additionally, he examines the genetic factors influencing treatment responses and cancer progression across different racial and ethnic groups.

Articles (9)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Brian Walker

Indiana State University

UNITED STATES

View details

Ryan Gentzler

University of Virginia

UNITED STATES

View details

Bachisio Ziccheddu

Sylvester Comprehensive Cancer Center, University of Miami

UNITED STATES

View details

Patrick Dillon

Assistant Professor

University of Virginia

UNITED STATES

View details

Todd Stukenberg

Professor

University of Virginia Hospital

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Oliver Hampton

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Genomic Classification and Individualized Prognosis in Multiple Myeloma.

CK1δ and CK1ε Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple Myeloma.

Whole-Exome sequencing analysis identified TMSB10/TRABD2A locus to be associated with carfilzomib-related cardiotoxicity among patients with multiple myeloma.

Replicative Instability Drives Cancer Progression

Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma.

Plasma cell dependence on histone/protein deacetylase 11 reveals a therapeutic target in multiple myeloma.

Metabolic Changes Are Associated with Melphalan Resistance in Multiple Myeloma.

DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden

NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells.

Collaborators (5)

Brian Walker

Ryan Gentzler

Bachisio Ziccheddu

Patrick Dillon

Todd Stukenberg

Make your next move.